Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence have?
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence has 191 citations in the OpenAlex counts ScholarIQ stores.
When was Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence published?
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence has 2020 year in the ScholarIQ index.
What is the open-access status of Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence?
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence has closed oa status in the ScholarIQ index.
What is the DOI of Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence?
The DOI for Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence is on the source record.
What is the PMID of Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence?
The PMID for Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence is on the source record.
What is the OpenAlex record for Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence?
The OpenAlex for Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence is on the source record.